Tyche Industries

Why is Tyche Industries Ltd falling/rising?

As of 09-Aug, Tyche Industries Ltd's stock price is Rs 124.10, down 1.51%, underperforming its sector. Despite a year-to-date increase of 7.08%, it has declined 10.72% over the past year and 37.40% over three years, indicating long-term weakness compared to the Sensex.

As of 09-Aug, Tyche Industries Ltd is experiencing a decline in its stock price, currently at Rs 124.10, which reflects a change of -1.9 (-1.51%). This decrease is evident as the stock has underperformed its sector by -2.95% today. Additionally, the stock reached an intraday low of Rs 122.1, marking a drop of -3.1%. <BR><BR>In terms of performance over various periods, the stock has shown a year-to-date increase of +7.08%, which contrasts with a significant decline of -10.72% over the past year and a more substantial drop of -37.40% over the last three years. This long-term underperformance is notable when compared to the Sensex, which has shown positive returns over the same periods.<BR><BR>Furthermore, while the stock is currently trading above its 200-day moving average, it is below its 5-day, 20-day, 50-day, and 100-day moving averages, indicating a short-term weakness in price momentum. Despite a notable increase in investor participation, with delivery volume rising by 354.98% against the 5-day average, the overall market sentiment appears to be negative, contributing to the stock's decline.

Which are the latest news on Tyche Industries?

When is the next results date for Tyche Industries Ltd?

The next results date for Tyche Industries Ltd is 11 August 2026.

The next results date for Tyche Industries Ltd is scheduled for 11 August 2026.

Should I buy, sell or hold Tyche Industries Ltd?

What does Tyche Industries do?

Tyche Industries Ltd is a micro-cap company in the Pharmaceuticals & Biotechnology sector, specializing in the manufacture of Glucosamine Hydrochloride and bulk drug intermediates. As of March 2026, it reported net sales of 16 Cr and a net profit of 1 Cr, with a market cap of INR 134 Cr.

Overview:<BR>Tyche Industries Ltd is a micro-cap company in the Pharmaceuticals & Biotechnology industry, primarily engaged in the manufacture of Glucosamine Hydrochloride and bulk drug intermediates.<BR><BR>History:<BR>Tyche Industries Limited was initially incorporated as Siris Soft Limited in 1998 and changed its name in 2004. The latest quarterly results reported net sales and net profit for the period ending March 2026.<BR><BR>Financial Snapshot:<BR>- Net Sales: 16 Cr (Quarterly Results - Mar 2026)<BR>- Net Profit: 1 Cr (Quarterly Results - Mar 2026)<BR>- Market Cap: INR 134 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 19.00<BR>- Industry P/E: 42<BR>- Dividend Yield: 2.34%<BR>- Debt Equity: -0.54<BR>- Return on Equity: 4.93%<BR>- Price to Book: 0.93<BR><BR>Contact Details:<BR>Address: H No C-21/A Road No 9, Film Nagar Jubilee Hills Hyderabad Telangana : 500096 <BR>Tel: 91-40-23541688/23540933 <BR>Email: CS@tycheindustries.net <BR>Website: http://wwww.tycheindustries.net

How big is Tyche Industries?

As of 10th June, Tyche Industries Ltd has a market capitalization of 134.00 Cr, with recent net sales of 53.64 Cr and a net profit of 6.92 Cr. Shareholder's funds are 136.70 Cr, and total assets amount to 147.41 Cr as of March 2025.

As of 10th June, Tyche Industries Ltd has a market capitalization of 134.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Tyche Industries reported Net Sales of 53.64 Cr and a Net Profit of 6.92 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 136.70 Cr and Total Assets of 147.41 Cr.

Who are in the management team of Tyche Industries?

The management team of Tyche Industries includes G Ganesh Kumar (Chairman & Managing Director), Boosa Eswar and Panchakarla Sai Sudhakar (Independent Directors), P Vijaya Lakshmi (Director), G Sandeep Kumar (Executive Director), Venkataraju Gupta Kollepalli and Srinivas Gelli (Non-Executive Directors), and Satya Ranjan Jena (Company Secretary & Compliance Officer).

The management team of Tyche Industries includes the following individuals:<BR><BR>1. G Ganesh Kumar - Chairman & Managing Director<BR>2. Boosa Eswar - Independent Director<BR>3. P Vijaya Lakshmi - Director<BR>4. Panchakarla Sai Sudhakar - Independent Director<BR>5. G Sandeep Kumar - Executive Director<BR>6. Venkataraju Gupta Kollepalli - Non-Executive Director<BR>7. Satya Ranjan Jena - Company Secretary & Compliance Officer<BR>8. Srinivas Gelli - Non-Executive Director<BR><BR>If you need more details about any specific member or their roles, feel free to ask!

Who are the peers of the Tyche Industries?

Tyche Industries' peers include Alpa Laboratorie, Bal Pharma, Smruthi Organic, Lactose (India), Godavari Drugs, Concord Drugs, Denis Chem Lab, Pharmaids Pharma, and Balaxi Pharma. In terms of management risk, growth, and capital structure, Alpa Laboratorie and Lactose (India) stand out positively, while Concord Drugs has the highest 1-year return at 161.37%, and Pharmaids Pharma has the lowest at -52.99%.

Peers: The peers of Tyche Industries are Alpa Laboratorie, Bal Pharma, Smruthi Organic, Lactose (India), Godavari Drugs, Concord Drugs, Denis Chem Lab, Pharmaids Pharma, and Balaxi Pharma.<BR><BR>Quality Snapshot: Excellent management risk is observed at Alpa Laboratorie, Denis Chem Lab, and Balaxi Pharma, while Average management risk is found at Bal Pharma, Smruthi Organic, Godavari Drugs, and Tyche Industries. Below Average management risk is noted at Lactose (India), Concord Drugs, Pharmaids Pharma, and Sotac Pharma. For Growth, Excellent growth is seen at Lactose (India), while Good growth is observed at Smruthi Organic, and the rest have Below Average growth. In terms of Capital Structure, Excellent capital structure is noted at Alpa Laboratorie, Tyche Industries, and Balaxi Pharma, while Good capital structure is found at Smruthi Organic, and the rest have Below Average capital structure.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Concord Drugs at 161.37%, while Pharmaids Pharma has the lowest at -52.99%. Tyche Industries' 1-year return is -10.46%, which is higher than Pharmaids Pharma but lower than Concord Drugs. Additionally, Lactose (India), Denis Chem Lab, Pharmaids Pharma, and Bal Pharma have negative six-month returns.

Are Tyche Industries Ltd latest results good or bad?

Tyche Industries Ltd's latest results are largely negative, showing a 53.12% increase in net sales but a 36.81% decline in net profit, with an alarming operating margin of -4.07%. The company's heavy reliance on non-operating income raises concerns about its operational efficiency and future performance.

Tyche Industries Ltd's latest results present a mixed picture, leaning towards negative overall. While the company reported a significant increase in net sales for Q4 FY26, reaching ₹16.20 crores—a 53.12% increase from the previous quarter—this growth was overshadowed by a substantial decline in net profit, which fell to ₹1.15 crores, down 36.81% quarter-on-quarter and 22.34% year-on-year.<BR><BR>The operating margin, excluding other income, was particularly concerning, landing at -4.07%, marking the lowest performance in seven quarters. This indicates that the company's core operations are struggling to generate profit, which raises questions about its operational efficiency and cost management.<BR><BR>Moreover, the company's reliance on non-operating income to maintain profitability is alarming. In Q4 FY26, other income accounted for 174.12% of profit before tax, suggesting that without these non-operating gains, the company would have reported a loss.<BR><BR>Overall, while the sales growth is a positive sign, the deteriorating profit margins and heavy dependence on other income indicate significant operational challenges that Tyche Industries needs to address urgently. Therefore, the latest results can be viewed as more negative than positive, reflecting underlying issues that could impact future performance.

Is Tyche Industries overvalued or undervalued?

As of November 19, 2025, Tyche Industries is considered overvalued with a PE ratio of 13.01 and an EV to EBITDA of 15.16, lagging behind peers like Solar Industries and Godrej Industries, and has a year-to-date return of -36.01% compared to the Sensex's 9.02%.

As of 19 November 2025, Tyche Industries has moved from a fair to an expensive valuation grade. The company is currently considered overvalued based on its financial ratios and peer comparisons. Key ratios include a PE ratio of 13.01, an EV to EBITDA of 15.16, and a Price to Book Value of 0.89, which indicate that the stock is trading at a premium compared to its earnings and book value.<BR><BR>In comparison to its peers, Tyche Industries' valuation appears less favorable; for instance, Solar Industries has a PE ratio of 94.38 and an EV to EBITDA of 58.08, while Godrej Industries shows a more attractive PE of 37.28 and an EV to EBITDA of 40.76. The significant divergence in valuation metrics suggests that Tyche Industries is not only overvalued relative to its own historical performance but also compared to its industry peers. Additionally, the company's recent stock performance has lagged behind the Sensex, with a year-to-date return of -36.01% compared to the Sensex's 9.02%, reinforcing the perception of overvaluation.

How has been the historical performance of Tyche Industries?

Tyche Industries has experienced declining net sales and profits from March 2023 to March 2025, with net sales dropping from INR 75.39 crore to INR 65.47 crore and profit after tax decreasing from INR 14.17 crore to INR 12.41 crore. However, total assets increased from INR 136.72 crore to INR 147.41 crore, primarily due to a rise in cash reserves.

Answer:<BR>The historical performance of Tyche Industries shows a fluctuating trend in key financial metrics over the years, with notable changes in net sales, profits, and assets.<BR><BR>Breakdown:<BR>Tyche Industries' net sales have seen a decline from INR 75.39 crore in March 2023 to INR 65.47 crore in March 2025, reflecting a downward trend over the last two years. The total operating income followed a similar pattern, decreasing from INR 75.39 crore in March 2023 to INR 65.47 crore in March 2025. Operating profit (PBDIT) also decreased from INR 20.98 crore in March 2023 to INR 18.71 crore in March 2025, indicating a reduction in profitability. The profit before tax showed a decline from INR 19.08 crore in March 2023 to INR 16.71 crore in March 2025, while profit after tax slightly decreased from INR 14.17 crore to INR 12.41 crore during the same period. On the balance sheet, total assets increased from INR 136.72 crore in March 2023 to INR 147.41 crore in March 2025, driven by growth in cash and bank balances, which rose from INR 69.28 crore to INR 84.26 crore. Total liabilities also increased from INR 136.72 crore to INR 147.41 crore, with no long-term or short-term borrowings reported throughout the years. Overall, Tyche Industries has experienced a mixed performance with declining sales and profits but an increase in total assets and cash reserves.

Who are the top shareholders of the Tyche Industries?

The top shareholders of Tyche Industries include Silver Oak Technologies Private Limited with 19.31%, followed by Plutus Techlabs Private Limited at 6.4%. Individual investors collectively own 26.91%, and there are no mutual funds or foreign institutional investors involved.

The top shareholders of Tyche Industries include Silver Oak Technologies Private Limited, which holds the highest stake at 19.31%. The company is primarily owned by its promoters, and there are no pledged promoter holdings. In terms of public shareholders, Plutus Techlabs Private Limited is the largest, with a holding of 6.4%. Additionally, individual investors collectively own 26.91% of the company. There are currently no mutual funds or foreign institutional investors holding shares in Tyche Industries.

What is the technical trend for Tyche Industries?

As of June 2, 2025, Tyche Industries shows a mildly bearish trend overall, with mixed signals from key indicators like MACD and KST, while daily moving averages remain bearish.

As of 2 June 2025, the technical trend for Tyche Industries has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD remains bearish. The RSI shows no signal on the weekly chart but is bullish on the monthly chart. Bollinger Bands are mildly bearish on both weekly and monthly time frames. Daily moving averages are bearish, and the KST is mildly bullish weekly but bearish monthly. Dow Theory shows no trend in both weekly and monthly perspectives. Overall, the current technical stance is mildly bearish, with key indicators being the bearish moving averages and the mixed signals from MACD and KST.

Has Tyche Industries declared dividend?

Yes, Tyche Industries has declared a dividend of 25% (amounting to $2.5 per share) with an ex-date of September 20, 2024. While the dividend yield is 1.79%, total returns have shown significant volatility, with negative returns in shorter periods and more favorable outcomes over the longer term.

Tyche Industries has declared a dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 25%<BR>- Amount per share: 2.5<BR>- Ex-date: 20 Sep 24<BR><BR>Dividend Yield: 1.79%.<BR><BR>Total Returns by Period:<BR>In the 6-month period, the price return was -34.69%, the dividend return was 0%, resulting in a total return of -34.69%.<BR><BR>For the 1-year period, the price return was -22.71%, the dividend return was 1.41%, leading to a total return of -21.3%.<BR><BR>Over 2 years, the price return was -23.92%, the dividend return was 2.40%, culminating in a total return of -21.52%.<BR><BR>In the 3-year period, the price return was 7.64%, the dividend return was 5.14%, resulting in a total return of 12.78%.<BR><BR>For the 4-year period, the price return was -36.26%, the dividend return was 3.09%, leading to a total return of -33.17%.<BR><BR>In the 5-year period, the price return was 26.65%, the dividend return was 6.46%, resulting in a total return of 33.11%.<BR><BR>Overall, Tyche Industries has declared a dividend, but the total returns over various periods show significant volatility, with negative returns in the shorter terms and a more favorable outcome over the longer term.